Uveitis Trial, Recruiting (NCT06273748)

Uveitis Trial, Recruiting NCT06273748 Sponsor: Meyer Children's Hospital IRCCS Condition: Uveitis

Printed from Voxsanity (voxsanity.com.au) — NCT06273748 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Uveitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You were diagnosed with long-term (chronic) eye inflammation (uveitis) that is not caused by an infection, and this diagnosis was made before you turned 16
You (or your parent/guardian if applicable) have signed a consent form agreeing to take part in the trial

Who may not be able to join:

Your eye inflammation (uveitis) is caused by an infection
You have a history of cancer or any malignant (harmful tumour) condition
You have a history of a condition that damages the protective covering of the nerves in the brain or spinal cord (such as multiple sclerosis) (confirm with trial site)
You have a history of inflammation of the blood vessels in the brain (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3297973141

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06273748

Sponsor: Meyer Children's Hospital IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Uveitis

Trial contact: 3297973141

More information: https://clinicaltrials.gov/study/NCT06273748

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You were diagnosed with long-term (chronic) eye inflammation (uveitis) that is not caused by an infection, and this diagnosis was made before you turned 16
You (or your parent/guardian if applicable) have signed a consent form agreeing to take part in the trial

Who may not be able to join:

Your eye inflammation (uveitis) is caused by an infection
You have a history of cancer or any malignant (harmful tumour) condition
You have a history of a condition that damages the protective covering of the nerves in the brain or spinal cord (such as multiple sclerosis) (confirm with trial site)
You have a history of inflammation of the blood vessels in the brain (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Meyer Children's Hospital IRCCS

Registry

ClinicalTrials.gov

Start date

10 February 2022

Est. completion

1 February 2032

Where this trial is recruiting

🇧🇪 Belgium 🇬🇷 Greece 🇮🇹 Italy Turkey (Türkiye) 🇺🇸 United States

Primary endpoints

Describe a population of paediatric patients with chronic non-infectious uveitis; Describe a population of paediatric patients with chronic non-infectious uveitis; Identify any differences between the different forms of uveitis in terms of characteristics and outcomes; Identify risk factors for a more severe course; Frequency achievement of response for each drug according to the definition of response; Time to archieve the response after drug initiation; Achievement of inactive disease on therapy according to the definition of MIWGUC; Time to achieve inactive disease on therapy according to t...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov